Heart One lot of sample bottles with eight 90-mg tablets of the widely used antiplatelet is being recalled after reports that one such bottle also contained pills of a drug for gout.
Heartwire from Medscape Facebook founder Mark Zuckerberg and his wife, Priscilla Chan, MD, a pediatrician, are investing $3 billion to help cure, prevent, or manage all disease.
Medscape Medical News Dr Jeffrey Weber previews five melanoma treatment studies that he considers the ones to watch; one, he predicts, will be practice-changing.
Medscape Oncology Dr John Marshall previews the GI cancer studies being presented at ASCO with his picks for the ones to watch, and predicts that a plenary presentation may be practice-changing.
Medscape Oncology An expert panel is tackling the first revision to the multiple sclerosis diagnostic criteria in 7 years. Among proposed changes is a greater role for cerebrospinal fluid evaluation.
Medscape Medical News The report by the nonpartisan Congressional Budget Office evaluates last-minute changes made to the bill to help propel it to passage.
Kaiser Health News Chrondroitin sulfate is as good as a common anti-inflammatory drug for knee osteoarthritis, according to a new European study.
WebMD Health News It's early days for them, but two genetics-inspired agents took different aims at the same metabolic pathway, and cut lipoprotein and triglyceride levels and reversed experimental atherosclerosis.
Heartwire from Medscape MRI in patients with cardiac devices, statins in the elderly, deprescribing, CRT and radial artery catheterization are discussed in this week’s podcast.
theheart.org on Medscape The sodium-glucose cotransporter 2 (SGLT2) inhibitor class is now listed clearly as a second-line option after metformin in type 2 diabetes.
Heartwire from Medscape Medscape sits down with two neurologists to discuss advances in multiple sclerosis as presented at this year's American Academy of Neurology Annual Meeting.
Medscape Neurology Recent ASCO annual meetings have featured practice-changing data in prostate cancer. Dr David Graham predicts that the ASCO 2017 annual meeting will be no different.
Medscape Oncology Read clinically focused news coverage of key developments from ADA 2017.
Medscape Diabetes & Endocrinology In the United States, death rates from Alzheimer's disease increased 55% from 1999 to 2014, according to just-released data from the CDC's Morbidity and Mortality Weekly Report.
Medscape Medical News Dr William Basco comments on a study that evaluated whether state-level policies and laws on opioid prescribing have had any impact.
Medscape Pediatrics The National Institutes of Health Precision Medicine Initiative, first announced by President Obama, will roll out in a political climate that is drawing attention to medical biases.
Medscape Medical News Dr Kathy Miller points to PARP inhibitors and pertuzumab as highpoints of the breast cancer program at the upcoming ASCO meeting, including the plenary presentation of the OlympiAD trial.
Medscape Oncology Dr Markman previews the latest research on gynecologic cancer to be presented at the upcoming ASCO meeting.
Medscape Oncology With this review of the new literature, Dr David Johnson wants to put the risks associated with proton pump inhibitors into perspective and quiet the noise.
869 new pubmed citations were retrieved for your search. Click on the search hyperlink below to display the complete search results:
These pubmed results were generated on 2017/05/26
PubMed comprises more than millions of citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.